Skip to main content

Anhedonia as a Crucial Factor of Depression: Assessment, Neurobiological Underpinnings and Treatment

  • Chapter
  • First Online:
Understanding Depression

Abstract

Anhedonia is a cardinal symptom of major depressive disorder yet has not received significant attention in the research domain. A major contributor to this disproportionality is the limited understanding of anhedonia. Traditionally conceptualized as a “loss of pleasure”, it is clear that anhedonia includes additional facets including interest, motivation and reward learning. With the construct of anhedonia expanded, the development of new assessment tools, including self-report scales and behavioural tasks, has greatly improved our understanding of the underlying neurobiology. Deficits in nucleus accumbens activity have historically been tied to anhedonia due to its attribution as a “pleasure centre” in the brain. However, it is now known that many other brain regions are involved in the processing of reward. Furthermore, many first-line antidepressant options focus primarily on potentiating serotonin levels, despite dopamine playing an essential role in anhedonia. A greater understanding of anhedonia may allow for more personalized treatment strategies and heavily reduce the significant burden associated with depression. This chapter will review the neurobiology, measurement and treatment of this core symptom of MDD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol. 1976;85:374–82.

    Article  CAS  Google Scholar 

  • Chase HW, Michael A, Bullmore ET, Sahakian BJ, Robbins TW. Paradoxical enhancement of choice reaction time performance in patients with major depression. J Psychopharmacol. 2010;24(4):471-479.

    Article  Google Scholar 

  • Clark DC, Fawcett J, Salazar-Grueso E, Fawcett E. Seven-month clinical outcome of anhedonic and normally hedonic depressed inpatients. Am J Psychiatry. 1984;141:1216–20.

    Article  CAS  Google Scholar 

  • Cohen MX, Axmacher N, Lernartz G, Baup N, Fossati P, Pessiglione M. Neuroelectric signatures of reward learning and decision-making in the human nucleus accumbens. Neuropsychopharmacology. 2009;34:1649–58.

    Article  Google Scholar 

  • Cools R, Blackwell A, Clark L, Menzies L, Cox S, Robbin TW. Tryptophan depletion disrupts the motivational guidance of goal-directed behaviour as a function of trait impulsivity. Neuropsychopharmacology. 2005;30:1362–73.

    Article  CAS  Google Scholar 

  • Dekeyne A, Gobert A, Auclair A, Girardon S, Millan M. Differential modulation of efficiency in a food-rewarded ‘differential reinforcement of low-rate’ 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors. Psychopharmacology. 2002;162:156–67.

    Article  CAS  Google Scholar 

  • Demyttenaere K, Corruble E, Hale A, Quera-Salva MA, Picarel-Blanchot F, Kasper S. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline. CNS Spectr. 2013;18(3):163–70.

    Article  Google Scholar 

  • Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012;35:68–77.

    Article  CAS  Google Scholar 

  • Dombrovski AY, Siegle GJ, Szanto K, Clark L, Reynolds CF, Aizenstein H. The temptation of suicide: striatal gray matter, discounting of delayed rewards, and suicide attempts in late-life depression. Psychol Med. 2012;42:1203–15.

    Article  CAS  Google Scholar 

  • Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007;64(3):327–37.

    Article  CAS  Google Scholar 

  • Elliott R, Friston KJ, Dolan RJ. Dissociable neural responses in human reward systems. J Neurosci. 2000;20:6159–65.

    Article  CAS  Google Scholar 

  • Fawcett J, Clark DC, Scheftner WA, Gibbons RD. Assessing anhedonia in psychiatric patients. Arch Gen Psychiatry. 1983;40:79–84.

    Article  CAS  Google Scholar 

  • Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM, Brown SM, Ryan ND, Birmaher B, Axelson DA, Dahl RE. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry. 2009;166:64–73.

    Article  Google Scholar 

  • Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM, Alonso CM, Shungu DC. Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry. 2012;69:139–49.

    Article  CAS  Google Scholar 

  • Gard DE, Gard MG, Kring AM, John OP. Anticipatory and consummatory components of the experience of pleasure: a scale development study. J Res Pers. 2006;40:1086–102.

    Article  Google Scholar 

  • Gard DE, Kring AM, Gard MG, Horan WP, Green MF. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007;93:253–60.

    Article  Google Scholar 

  • Garfield JB, Cotton SM, Lubman DI. Psychometric properties, validity, and reliability of the temporal experience of Pleasure Scale state version in an opioid-dependent sample. Drug Alcohol Depend. 2016;161:238–46.

    Article  Google Scholar 

  • Gargoloff PD, Corral R, Herbst L, Marquez M, Martinotti G, Gargoloff PR. Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study. Hum Psychopharmacol Clin Exp. 2016;31(6):412–8.

    Article  CAS  Google Scholar 

  • Gooding DC, Pflum MJ. The assessment of interpersonal pleasure: introduction of the Anticipatory and Consummatory Interpersonal Pleasure Scale (ACIPS) and preliminary findings. Psychiatry Res. 2014;215:237–43.

    Article  Google Scholar 

  • Grabenhorst F, Rolls ET. Value, pleasure and choice in the ventral prefrontal cortex. Trends Cogn Sci. 2011;15:56–67.

    Article  Google Scholar 

  • Green L, Myerson J, McFadden E. Rate of temporal discounting decreases with amount of reward. Mem Cogn. 1997;25:715–23.

    Article  CAS  Google Scholar 

  • Hamilton JP, Furman DJ, Chang C, et al. Default-mode and task-positive network activity in major depressive disorder: implications for adaptive and maladaptive rumination. Biol Psychiatry. 2011;70:327–33.

    Article  Google Scholar 

  • Hasler G, Mondillo K, Drevets WC, Blair JR. Impairments of probabilistic response reversal and passive avoidance following catecholamine depletion. Neuropsychopharmacology. 2009;34:2691–8.

    Article  CAS  Google Scholar 

  • Henriques JB, Davidson RJ. Decreased responsiveness to reward in depression. Cognit Emot. 2000;14:711–24.

    Article  Google Scholar 

  • Hess JL, Kawaguchi DM, Wagner KE, Faraone SV, Glatt SJ. The influence of genes on “positive valence systems” constructs: a systematic review. Am J Med Genet B Neuropsychiatr Genet. 2016;171B(1):92–110.

    Article  Google Scholar 

  • Hsu DT, Sanford BJ, Meyers KK, Love TM, Hazlett KE, Walker SJ, Mickey BJ, Koeppe RA, Langenecker SA, Zubieta JK. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Mol Psychiatry. 2015;20(2):193–200.

    Article  CAS  Google Scholar 

  • Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167(7):748–51.

    Article  Google Scholar 

  • Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992;12:483–8.

    Article  CAS  Google Scholar 

  • Kennedy SH, Giacobbe P. Treatment resistant depression—advances in somatic therapies. Ann Clin Psychiatry. 2007;19:279–87.

    Article  Google Scholar 

  • Kennedy SH, Rizvi SJ. Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness. CNS Drugs. 2010;24(6):479–99.

    Article  CAS  Google Scholar 

  • Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Muller DJ, Parikh SV, Pearson NL, Ravindran AV, Uher R, CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016;61:540–60.

    Article  Google Scholar 

  • Kirby N, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen. 1999;128:78–87.

    Article  CAS  Google Scholar 

  • Knutson B, Bhanji J, Cooney R, Atlas L, Gotlib I. Neural responses to monetary incentives in major depression. Biol Psychiatry. 2008;63:686–92.

    Article  Google Scholar 

  • Kring AM, Barch DM. The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. Eur Neuropsychopharmacol. 2014;24:725–36.

    Article  CAS  Google Scholar 

  • Kringelbach ML, Stein A, Van Hartevelt TJ. The functional human neuroanatomy of food pleasure cycles. Physiol Behav. 2012;106:307–16.

    Article  CAS  Google Scholar 

  • Kugaya A, Sanacora G, Verhoeff NP, Fujita M, Mason GF, Seneca NM, Bozkurt A, Khan SA, Anand A, Degen K, Charney DS, Zoghbi SS, Baldwin RM, Seibyl JP, Innis RB. Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT. Biol Psychiatry. 2003;54:792–9.

    Article  CAS  Google Scholar 

  • Kumar P, Waiter G, Ahearn T, Milders M, Reid I, Steele JD. Abnormal temporal difference reward-learning signals in major depression. Brain. 2008;131:2084–93.

    Article  CAS  Google Scholar 

  • Kumar P, Berghorst LH, Nickerson LD, Dutra SJ, Goer FK, Greve DN, Pizzagalli DA. Differential effects of acute stress on anticipatory and consummatory phases of reward processing. Neuroscience. 2014;266:1–12.

    Article  CAS  Google Scholar 

  • Lam RW, Wang J, Enns MW, Kolivakis T, Michalak EE, Sareen J, Song W, Kennedy SH, MacQueen GM, Milev RV, Parikh SV, Ravindran AV, CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care. Can J Psychiatry. 2016;61:510–23.

    Article  Google Scholar 

  • Leventhal AM, Chasson GS, Tapia E, Miller EK, Pettit JW. Measuring hedonic capacity in depression: a psychometric analysis of three anhedonia scales. J Clin Psychol. 2006;62:1545–58.

    Article  Google Scholar 

  • Lipsman N, Sankar T, Downar J, Kennedy SH, Lozano AM, Giacobbe P. Neuromodulation for treatment-refractory major depressive disorder. CMAJ. 2014;186(1):33–9.

    Article  Google Scholar 

  • Malhi GS, Berk M. Does dopamine dysfunction drive depression? Acta Psychiatr Scand. 2007;115(Suppl 433):116–24.

    Article  Google Scholar 

  • Malhi GS, Parker GB, Crawford J, Wilhelm K, Mitchell PB. Treatment-resistant depression: resistant to definition? Acta Psychiatr Scand. 2005;112(4):302–9.

    Article  CAS  Google Scholar 

  • Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–60.

    Article  CAS  Google Scholar 

  • McCabe C, Cowen PJ, Harmer CJ. Neural representation of reward in recovered depressed patients. Psychopharmacology. 2009;205:667–77.

    Article  CAS  Google Scholar 

  • McCabe C, Mishor Z, Cowen PJ, Harmer CJ. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry. 2010;67(5):439–45.

    Article  CAS  Google Scholar 

  • McMakin DL, Olino TM, Porta G, Dietz DJ, Emslie G, Clarke G, Wagner KD, Asarnow JR, Ryan ND, Birmaher B, Shamseddeen W, Mayes T, Kennard B, Spirito A, Keller M, Lynch FL, Dickerson JF, Brent DA. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor-treatment resistant depression. J Am Acad Child Adolesc Psychiatry. 2012;51(4):404–11.

    Article  Google Scholar 

  • Murphy FC, Michael A, Robbins TW, Sahakian BJ. Neuropsychological impairments in patients with major depressive disorder: the effects of feedback on task performance. Psychol Med. 2003;33:455–67.

    Article  CAS  Google Scholar 

  • Pechtel P, Dutra S, Goetz E, Pizzagalli D. Blunted reward responsiveness in remitted depression. J Psychiatr Res. 2013;47:1864–9.

    Article  Google Scholar 

  • Pessiglione M, Petrovic P, Daunizeau J, Palminteri S, Dolan RJ, Frith CD. Subliminal instrumental conditioning demonstrated in the human brain. Neuron. 2008;59:561–7.

    Article  CAS  Google Scholar 

  • Pizzagalli DA, Jahn AL, O’Shea JP. Toward an objective characterization of an anhedonic phenotype: a signal-detection approach. Biol Psychiatry. 2005;57:319–27.

    Article  Google Scholar 

  • Pizzagalli DA, Losifescu D, Hallett LA, Ratner KG, Fava M. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res. 2008;43:76–87.

    Article  Google Scholar 

  • Prevost C, Pessiglione M, Metereau E, Clery-Melin ML, Dreher JC. Separate valuation subsystems for delay and effort decision costs. J Neurosci. 2010;30(42):14080–90.

    Article  CAS  Google Scholar 

  • Pulcu E, Trotter PD, Thomas EJ, McFarquhar M, Juhasz G, Sahakian BJ, Deakin JF, Zahn R, Anderson IM, Elliott R. Temporal discounting in major depressive disorder. Psychol Med. 2014;44:1825.

    Article  CAS  Google Scholar 

  • Rawal A, Collishaw S, Thapar A, Rice F. ‘The risks of playing it safe’: a prospective longitudinal study of response to reward in the adolescent offspring of depressed parents. Psychol Med. 2013;43:27–38.

    Article  CAS  Google Scholar 

  • Richards JB, Zhang L, Mitchell SH, de Wit H. Delay or probability discounting in a model of impulsive behavior: effect of alcohol. J Exp Anal Behav. 1999;71:121–43.

    Article  CAS  Google Scholar 

  • Rizvi SJ, Geraci J, Ravindran A, Kennedy SH. Predictors of response to adjunctive osmotic-release methylphenidate or placebo in patients with major depressive disorder: effects of apathy/anhedonia and fatigue. J Clin Psychopharmacol. 2014a;34(6):755–9.

    Article  Google Scholar 

  • Rizvi SJ, Grima E, Tan M, Rotzinger S, Lin P, McIntyre RS, Kennedy SH. Treatment-resistant depression in primary care across Canada. Can J Psychiatr. 2014b;59(7):349–57.

    Article  Google Scholar 

  • Rizvi SJ, Quilty LC, Sproule BA, Cyriac A, Michael Bagby R, Kennedy SH. Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in a community sample and individuals with major depression. Psychiatry Res. 2015;229(1–2):109–19.

    Article  Google Scholar 

  • Rizvi SJ, Pizzagalli DA, Sproule BA, Kennedy SH. Assessing anhedonia in depression: potentials and pitfalls. Neurosci Biobehav Rev. 2016;65:21–35.

    Article  Google Scholar 

  • Salamone JD, Correa M, Mingote S, Weber SM. Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther. 2003;305:1–8.

    Article  CAS  Google Scholar 

  • Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, Collins LE, Sagar TN. Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism. Behav Brain Res. 2009;201:216–22.

    Article  CAS  Google Scholar 

  • Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 1999;56:1043–7.

    Article  CAS  Google Scholar 

  • Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, Joe AY, Kreft M, Lenartz D, Sturm V. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33(2):368–77.

    Article  Google Scholar 

  • Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol. 1998;80:1–27.

    Article  CAS  Google Scholar 

  • Schultz W. Updating dopamine reward signals. Curr Opin Neurobiol. 2013;23:229–38.

    Article  CAS  Google Scholar 

  • Seo H, Lee D. Temporal filtering of reward signals in the dorsal anterior cingulate cortex during a mixed-strategy game. J Neurosci. 2007;27:8366–77.

    Article  CAS  Google Scholar 

  • Sharma A, Wolf DH, Ciric R, Kable JW, Moore TM, Vandekar SN, Katchmar N, Daldal A, Ruparel K, Davatzikos C, Elliot MA, Calkins ME, Shinohara RT, Bassett DS, Satterthwaite TD. Common dimensional reward deficits across mood and psychotic disorders: a Connectome-Wide Association Study. Am J Psychiatr. 2017;174:657–66.

    Article  Google Scholar 

  • Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995;167:99–103.

    Article  CAS  Google Scholar 

  • Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O, Racagni G, Zohar J, Mendlewicz J. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol. 1999;9:83–91.

    Article  CAS  Google Scholar 

  • Sternat T, Katzman MA. Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsychiatr Dis Treat. 2016;12:2149–64.

    Article  CAS  Google Scholar 

  • Taylor Tavares JV, Clark L, Furey ML, Williams GB, Sahakian BJ, Drevets WC. Neural basis of abnormal response to negative feedback in unmedicated mood disorders. Neuroimage. 2008;42:1118–26.

    Article  Google Scholar 

  • Thomson KR. Measuring anhedonia: impaired ability to pursue, experience, and learn about reward. Front Psychol. 2015;6:1409.

    Article  Google Scholar 

  • Treadway MT. The neurobiology of motivational deficits in depression—an update on candidate pathomechanisms. Curr Top Behav Neurosci. 2015;27:337–55.

    Article  Google Scholar 

  • Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev. 2011;35(3):537–55.

    Article  Google Scholar 

  • Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH. Worth the ‘EEfRT’? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One. 2009;4:e6598.

    Article  Google Scholar 

  • Treadway MT, Bossaller N, Shelton RC, Zald DH. Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol. 2012;121(3):553–8.

    Article  Google Scholar 

  • Tremblay LK, Naranjo CA, Graham SJ, Herrmann N, Mayberg HS, Hevenor S, Busto UE. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry. 2005;62:1228–36.

    Article  Google Scholar 

  • Tso IF, Grove TB, Taylor SF. Differential hedonic experience and behavioral activation in schizophrenia and bipolar disorder. Psychiatry Res. 2014;219:470–6.

    Article  Google Scholar 

  • Uher R, Farmer A, Maier W, Rietschel M, Hauser J, Marusic A, Mors O, Elkin A, Williamson RJ, Schmael C, Henigsberg N, Perez J, Mendlewicz J, Janzing JG, Zobel A, Skibinska M, Kozel D, Stamp AS, Bajs M, Placentino A, Barreto M, McGuffin P, Aitchison KJ. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med. 2008;38:289–300.

    Article  CAS  Google Scholar 

  • Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, Hauser J, Dernovsek Z, Souery D, Bajs M, Maier W, Aitchison KJ, Farmer A, McGuffin P. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med. 2012;42(5):967–80.

    Article  CAS  Google Scholar 

  • Vengeliene V, Bespalov A, Robmanith M, Horschitz S, Berger S, Relo AL, Noori HR, Schneider P, Enkel T, Bartsch D, Schneider M, Behl B, Hansson AC, Schloss P, Spanagel R. Toward trans-diagnostic mechanisms in psychiatry: neurobehavioral profile of rats with a loss-of-function point mutation in the dopamine transporter gene. Dis Model Mech. 2017;10(4):451–61.

    Article  CAS  Google Scholar 

  • Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. The STAR*D project results: a comprehensive review of findings. Curr Psychiatry Rep. 2007;9(6):449–59.

    Article  Google Scholar 

  • Wassum KM, Ostlund SB, Maidment NT, Balleine BW. Distinct opioid circuits determine the palatability and the desirability of rewarding events. Proc Natl Acad Sci U S A. 2009;106:12512–7.

    Article  CAS  Google Scholar 

  • Whitton AE, Treadway MT, Pizzagalli DA. Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry. 2015;28(1):7–12.

    Article  Google Scholar 

  • Wong LS, Eshel G, Dreher J, Ong J, Jackson DM. Role of dopamine and GABA in the control of motor activity elicited from the rat nucleus accumbens. Pharmacol Biochem Behav. 1991;38:829–35.

    Article  CAS  Google Scholar 

  • World Health Organization. Depression fact sheet. 2017. http://www.who.int/mediacentre/factsheets/fs369/en/.

  • Zhang B, Lin P, Shi H, Ongur D, Auerbach RP, Wang X, Yao S, Wang X. Mapping anhedonia-specific dysfunction in a transdiagnostic approach: an ALE meta-analysis. Brain Imaging Behav. 2016;10:920–39.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sakina J. Rizvi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Chow, T.K., Kennedy, S., Rizvi, S.J. (2018). Anhedonia as a Crucial Factor of Depression: Assessment, Neurobiological Underpinnings and Treatment. In: Kim, YK. (eds) Understanding Depression. Springer, Singapore. https://doi.org/10.1007/978-981-10-6577-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-6577-4_7

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-6576-7

  • Online ISBN: 978-981-10-6577-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics